The Biopôle life sciences campus expands further

After the inauguration of its new 9,000-square-meter SE-B building in January 2018, the Biopôle has announced the construction of a new building on its site in Epalinges, Lausanne.

The delivery of the SB-A building is expected for the year 2020, bringing the Biopôle life sciences campus to a total constructed surface of 55,000 square meters | © Biopôle

Named SB-A, the new building will be dedicated to office and laboratory spaces for companies active in the life sciences field, from young startups to sector-leading businesses. With a surface area of approximately 10,000 square meters, the SB-A will host new companies, generating up to 300 new jobs and adding to the existing 1,200 life sciences professionals on site.

Nasri Nahas, CEO of Biopôle SA, commented : “The SB-A building has been conceived in response to the growing demand for flexible office and laboratory spaces at Biopôle. The canton of Vaud is known both nationally and internationally as a hub of innovation and Biopôle is increasingly recognized as “the place to be” for companies active in the field of life sciences. This building will further contribute towards the vibrant and innovative life sciences ecosystems in the canton of Vaud, and across Switzerland.” Construction of the new building is expected to start in February 2019 and is due to finish in Q2 2020.

More than 70 companies

Started in 2004 by the public authorities of the canton of Vaud, Biopôle is a life sciences community bringing together industry and academia. It offers a combination of high-­quality infrastructure, value-added services and living spaces that are well suited to ensuring the prosperity of the businesses based there. With a surface area of over 8 hectares, the site houses more than 70 companies and institutions, including several head offices of multinational corporations, start­ups and clinical development teams, together with technology and service providers. It also hosts 25 world-famous research groups, in particular the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL) and the Ludwig Institute for Cancer Research.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

¿Cómo desea que le contactemos?